Department of Hygiene and Public Health, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Int J Cardiol. 2021 Aug 15;337:105-112. doi: 10.1016/j.ijcard.2021.05.020. Epub 2021 May 13.
Although limited walking ability at discharge is a known risk factor for adverse outcomes in older patients with heart failure (HF), the association between pre-admission limitations and adverse outcomes is unknown. Therefore, we evaluated the prevalence of a pre-admission limitation in walking ability and its relationship with post-discharge outcomes among patients with HF with reduced, mid-range, and preserved left-ventricular ejection fraction (HFrEF, HFmrEF, and HFpEF).
We followed 2042 patients aged ≥65 years (HFrEF, n = 668; HFmrEF, n = 360; HFpEF, n = 1014) from a multicenter cohort study in Japan. A limitation in walking ability was defined as the necessity of any assistance or a walking aid. Adverse outcomes were defined as the composite of HF rehospitalization and all-cause death within 2 years after discharge.
During 2978.0 person-years of follow-up, 563 patients were rehospitalized due to HF exacerbation and 103 patients died. In HFrEF, HFmrEF, and HFpEF groups, the prevalence of a pre-admission limitation in walking ability was 12.1%, 18.6%, and 21.1%, respectively, the crude hazard ratios [95% confidence interval] of a pre-admission limitation in walking ability were 2.46 [1.79-3.39], 1.34 [0.87-2.06], and 1.94 [1.53-2.47], and the adjusted hazard ratios were 2.21 [1.58-3.16], 1.19 [0.75-1.89], and 1.39 [1.06-1.82], respectively.
A pre-admission limitation in walking ability is a predictor of post-discharge HF rehospitalization or all-cause death among patients with HFrEF and HFpEF, but not among patients with HFmrEF. Shortly after admission, information regarding pre-admission functional limitations should be obtained to better understand the risk of post-discharge adverse outcomes.
尽管出院时行走能力有限是老年心力衰竭(HF)患者不良结局的已知危险因素,但入院前的活动能力限制与不良结局之间的关系尚不清楚。因此,我们评估了射血分数降低(HFrEF)、射血分数中间值(HFmrEF)和射血分数保留(HFpEF)的心力衰竭患者入院前活动能力受限的发生率及其与出院后结局的关系。
我们随访了来自日本多中心队列研究的 2042 名年龄≥65 岁的患者(HFrEF,n=668;HFmrEF,n=360;HFpEF,n=1014)。行走能力受限定义为需要任何辅助或助行器。不良结局定义为出院后 2 年内心力衰竭再住院和全因死亡的复合结局。
在 2978.0 人年的随访期间,563 名患者因心力衰竭恶化而再次住院,103 名患者死亡。在 HFrEF、HFmrEF 和 HFpEF 组中,入院前行走能力受限的发生率分别为 12.1%、18.6%和 21.1%,入院前行走能力受限的粗风险比(95%置信区间)分别为 2.46(1.79-3.39)、1.34(0.87-2.06)和 1.94(1.53-2.47),调整后的风险比分别为 2.21(1.58-3.16)、1.19(0.75-1.89)和 1.39(1.06-1.82)。
入院前行走能力受限是 HFrEF 和 HFpEF 患者出院后心力衰竭再住院或全因死亡的预测因素,但不是 HFmrEF 患者的预测因素。入院后应尽快获取入院前的功能受限信息,以更好地了解出院后不良结局的风险。